Continental Advisors LLC Teva Pharmaceutical Industries LTD Transaction History

Continental Advisors LLC

$228 Million
Q2 2024

A detailed history of Continental Advisors LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Continental Advisors LLC holds 403,766 shares of TEVA stock, worth $7.07 Million. This represents 2.88% of its overall portfolio holdings.

Number of Shares

403,766

Previous 477,766 15.49%

Holding current value

$7.07 Million

Previous $6.74 Million 2.67%

% of portfolio

2.88%

Previous 2.72%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$12.78 - $17.4 $945,720 - $1.29 Million	-74,000 Reduced 15.49%	403,766 $6.56 Million
Q1 2024 May 15, 2024	BUY	$10.67 - $14.43 $1.74 Million - $2.35 Million	162,900 Added 51.74%	477,766 $6.74 Million
Q4 2023 Feb 14, 2024	SELL	$8.12 - $10.63 $211,119 - $276,380	-26,000 Reduced 7.63%	314,866 $3.29 Million
Q3 2023 Nov 14, 2023	SELL	$7.48 - $10.7 $542,300 - $775,750	-72,500 Reduced 17.54%	340,866 $3.48 Million
Q2 2023 Aug 14, 2023	BUY	$7.2 - $9.47 $313,675 - $412,570	43,566 Added 11.78%	413,366 $3.11 Million
Q1 2023 May 15, 2023	BUY	$8.36 - $11.37 $530,860 - $721,995	63,500 Added 20.73%	369,800 $3.27 Million
Q4 2022 Feb 14, 2023	BUY	$7.95 - $9.48 $1.04 Million - $1.24 Million	131,000 Added 74.73%	306,300 $2.79 Million
Q3 2022 Nov 14, 2022	SELL	$6.86 - $11.95 $536,355 - $934,322	-78,186 Reduced 30.84%	175,300 $1.42 Million
Q2 2022 Aug 15, 2022	SELL	$7.38 - $10.4 $184,500 - $260,000	-25,000 Reduced 8.98%	253,486 $1.91 Million
Q1 2022 May 16, 2022	SELL	$7.33 - $9.39 $73,300 - $93,900	-10,000 Reduced 3.47%	278,486 $2.62 Million
Q3 2021 Nov 15, 2021	BUY	$8.38 - $10.18 $243,020 - $295,220	29,000 Added 11.18%	288,486 $2.81 Million
Q2 2021 Aug 16, 2021	BUY	$9.9 - $11.56 $99,000 - $115,600	10,000 Added 4.01%	259,486 $2.57 Million
Q1 2021 May 17, 2021	SELL	$10.34 - $12.81 $103,400 - $128,100	-10,000 Reduced 3.85%	249,486 $2.88 Million
Q4 2020 Feb 16, 2021	BUY	$8.61 - $11.04 $1.09 Million - $1.39 Million	126,300 Added 94.83%	259,486 $2.5 Million
Q3 2020 Nov 16, 2020	SELL	$8.57 - $12.69 $257,100 - $380,700	-30,000 Reduced 18.38%	133,186 $1.2 Million
Q4 2019 Feb 10, 2020	SELL	$6.53 - $10.72 $52,612 - $86,371	-8,057 Reduced 4.71%	163,186 $1.6 Million
Q1 2019 May 14, 2019	SELL	$15.58 - $20.01 $920,108 - $1.18 Million	-59,057 Reduced 25.64%	171,243 $2.69 Million
Q3 2018 Nov 14, 2018	SELL	$21.06 - $25.65 $775,008 - $943,920	-36,800 Reduced 13.78%	230,300 $4.96 Million
Q2 2018 Aug 13, 2018	SELL	$16.77 - $24.71 $1.29 Million - $1.89 Million	-76,680 Reduced 22.3%	267,100 $6.5 Million
Q1 2018 May 14, 2018	BUY	$16.68 - $22.07 $850,680 - $1.13 Million	51,000 Added 17.42%	343,780 $5.88 Million
Q4 2017 Feb 13, 2018	BUY	$11.23 - $19.1 $425,392 - $723,508	37,880 Added 14.86%	292,780 $5.55 Million
Q3 2017 Nov 14, 2017	BUY	$15.41 - $32.17 $3.93 Million - $8.2 Million	254,900	254,900 $4.49 Million

Others Institutions Holding TEVA

# of Institutions

617

Shares Held

563M

Call Options Held

25.2M

Put Options Held

5.08M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Continental Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Continental Advisors LLC with notifications on news.

Account

Continental Advisors LLC Teva Pharmaceutical Industries LTD Transaction History